Now showing items 1-20 of 608

    • Bridging the gap : patients and professionals perspective on risk and recovery in forensic psychiatry 

      Pollak, Charlotte (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-10-08)
      Background: The aim of forensic psychiatry is to protect society and care for offenders with severe mental illness (SMI). People with severe mental illness show a certain increased risk of committing violent crimes, which ...
    • Brief online interventions for concerned gamblers in a gambling helpline 

      Wall, Håkan (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-09-23)
      Background: Problem gambling (PG) is common throughout the world and affects approximately 2% of the adult population in Sweden and most other western countries. Individuals who gamble in a problematic way experience ...
    • Subtypes of ischemic stroke : analysis of revascularization therapy, stroke etiology, and the role of blood pressure 

      Matusevičius, Marius (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-09-01)
      Background: Treatment with intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT) improve outcomes for patients with acute ischemic stroke. The efficacy and safety of IVT and EVT may differ based on specific ...
    • Tracking selective attention in a musical cocktail 

      Manting, Cassia Low (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-08-18)
      The cocktail party effect refers to mankind’s ability to focus attention on a single sound within noisy or complex auditory environments, in order to extract the most behaviourally-relevant information present. To investigate ...
    • Executive functions and successful behavior 

      Vestberg, Torbjörn (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-07-28)
      Executive functions are the underlying mechanisms that drive top-down regulation of information processing. While suboptimal executive functions have been investigated in various groups of patients, their impact and ...
    • Mechanisms of flavor perception : how odor and taste interact when we eat 

      Fondberg, Robin (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-06-02)
      Every time we eat, our brains are bombarded with sensory information from the olfactory and gustatory modalities. Through a binding process that is not fully understood, the odor and taste are then merged into flavor, a ...
    • Exposure-based cognitive behavior therapy for atrial fibrillation : a novel treatment paradigm 

      Särnholm, Josefin (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-28)
      Background: Atrial fibrillation (AF) is a prevalent arrhythmia associated with symptoms such as irregular heartbeat, palpitations, dyspnea, chest pain and fatigue. In many patients, AF symptoms are not alleviated by ...
    • An object's smell in the multisensory brain : how our senses interact during olfactory object processing 

      Porada, Danja K. (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-28)
      Object perception is a remarkable and fundamental cognitive ability that allows us to interpret and interact with the world we are living in. In our everyday life, we constantly perceive objects–mostly without being aware ...
    • Novel measure of olfactory bulb function in health and disease 

      Iravani, Behzad (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-26)
      Present neuroimaging techniques are capable of recording the neural activity from all over the brain but the olfactory bulb (OB). The OB is the first olfactory processing stage of the central nervous system and the site ...
    • Anti-CD20 therapy in multiple sclerosis : clinical and paraclinical outcomes 

      Juto, Alexander (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-25)
      Multiple sclerosis is a chronic inflammatory disease of the central nervous system and the most common non-traumatic cause of neurological disability in young adults. Rituximab is a B-cell depleting drug targeting the CD20 ...
    • Effects of child CBT and parent management training for children with disruptive behavioral disorders 

      Helander, Maria (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-21)
      Background: An early identification and treatment of children with disruptive behavior disorders such as oppositional defiant disorder and conduct disorder is important to prevent further development of psychiatric ...
    • Serious and violent offending : psychological risk factors and treatment effectiveness 

      Lardén, Martin (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-15)
      Background: Violent crime causes extensive suffering and costs to individuals and societies and is a major global health issue. Prevention of violence should occur at several levels, and effective psychological interventions ...
    • Novel intervention approaches after recent exposure to trauma 

      Bragesjö, Maria (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-12)
      Background: The life-time incidence of exposure to traumatic events is high and can have a profound negative impact on mental health. The majority of individuals exposed to trauma will go through a process of natural ...
    • Emotion dysregulation, self-image, and eating disorders 

      Monell, Elin (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-12)
      Background: Eating disorders (EDs) are complex psychiatric disorders that entail great suffering, high prevalence of comorbid psychiatric and somatic conditions, and increased mortality. The understanding of how EDs ...
    • Characterization and long-term follow-up of Pediatric Acute-onset Psychiatric Syndrome (PANS) 

      De Visscher, Caroline (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-05-07)
      Background Pediatric acute-onset neuropsychiatric syndrome (PANS) is a cluster of psychiatric and somatic symptoms of proposed autoimmune etiology. It remains a descriptive entity, still of unclear validity and uncertain ...
    • A neuroimaging perspective on regulation of emotion, reward, and attention 

      Bayard, Frida (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-04-22)
      Emotional symptoms and non-emotional symptoms such as inattention often co-occur. Each of these symptom domains covers symptoms that are distributed along a continuum across the population; from non-clinical levels to ...
    • Long-term aspects of stroke : survival, health-related quality of life and costs 

      Rudberg, Ann-Sofie (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-04-15)
      Stroke, a disease that affects millions of people globally every year, is an emergency situation requiring fast and immediate action in hospital. Acute stroke treatments have rapidly improved and been developed over the ...
    • Epiphora : impact on vision, outcome of lacrimal surgery and investigations with ultra-high-frequency ultrasound 

      Bohman, Elin (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-04-08)
      Epiphora is a common condition that often receives little attention. Excessive tear production creates an irregular and ever-changing ocular surface, affecting refraction and reducing vision. However, in a standard test ...
    • Recruitment to multicentre randomised controlled trials in stroke : lessons learnt from the effects trial 

      Isaksson, Eva (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-02-26)
      Randomised controlled trials are the gold standard for evaluation treatments. Nevertheless, recruitment into trials is still challenging and many trials fail to meet their recruitment goals within the predetermined time. ...
    • Method development for [11C]carbon monoxide radiochemistry 

      Ferrat, Mélodie (Inst för klinisk neurovetenskap / Dept of Clinical Neuroscience, 2021-02-25)
      Positron emission tomography (PET) is a non-invasive molecular imaging technique that has found extensive utility in biomedical research and in drug development. A fundamental pre-requisite for PET is the tracer, which is ...